|Last Price||48.29||Max Price||67.50|
|Min Price||45.05||1 Year return||-13.85|
Colruyt has located her head office Halle. The company mostly operates in the food & drug sector. The global food & drug retailers gained around 32 percent worldwide over the last 10 years. Measured since 2011 the sector is 27 percent higher and over the past 12 months (December 2015-December 2016) there is a minus of 32 percent.
Over the last 12 months (from December 2015 till December 2016), that were loss-making period for the investors in Colruyt, the stock lost around 3 percent. Over the period 2011-2016 the stock rose a massive 62,22 percent. Colruyt's revenues between 2011 and 2015 were very constant and moved between 7,85 billion euros and 8,92 billion euros. Colruyt's net incomes between 2011 and 2015 were quiet similar and moved between 338 million euros and 362,6 million euros.
The Belgian company paid out dividends in the past 5 years. On average the Colruyt stock yielded a delivered a dividend yield of around 4,87 percent over the past 5 years.
At the end of 2015 Colruyt employed at around 25,78 thousand people.
At the end of 2015 the Belgian company had a balance sheet of around 2,18 billion euros. The total debt of the food & drug retailer was at the end of 2015 379,5 million euros, which equals around 17,41 percent of the total balance sheet. Last year the food & drug retailer's price/earnings-ratio (PE) was around 16. So the investors valued the stock at 16 times 2015' earnings per share. Based on the classical stock valuation theories the Belgian stock can be seen as a value stock.
The food & drug retailer's market capitalization (the number of shares outstanding times the market value) equaled around 7,12 billion euros. At the end of 2015 the Belgian company had around 149,42 million stocks listed.